Francesco Dazzi

Best Publications

• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  Mauro Krampera;Sarah Glennie;Julian Dyson;Diane Scott

  2231
  Citations

• Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.

  Sarah Glennie;Inês Soeiro;Peter J. Dyson;Eric W.-F. Lam

  1563
  Citations

• Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

  Antonio Galleu;Yanira Riffo-Vasquez;Cristina Trento;Cara Lomas

  676
  Citations

• Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

  Rajesh Ramasamy;Henrietta Fazekasova;Eric W.-F. Lam;In s Soeiro

  621
  Citations

• Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

  R Ramasamy;E. W. F. Lam;I. Soeiro;Veronica Tisato

  553
  Citations

• International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

  Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  520
  Citations

• The role of mesenchymal stem cells in haemopoiesis.

  Francesco Dazzi;Rajesh Ramasamy;Sarah Glennie;Simon P. Jones

  509
  Citations

• Mesenchymal stem cells: the fibroblasts' new clothes?

  Muzlifah A. Haniffa;Matthew P. Collin;Christopher D. Buckley;Francesco Dazzi

  457
  Citations

• Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

  Myrtle Y. Gordon;Nataša Levičar;Madhava Pai;Philippe Bachellier

  422
  Citations

• European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

  David Marin;Dragana Milojkovic;Eduardo Olavarria;Jamshid S. Khorashad

  415
  Citations

• Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

  Francesco Dazzi;R. M. Szydlo;C. Craddock;N. C. Cross

  407
  Citations

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  394
  Citations

• Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.

  Francis Mussai;Carmela De Santo;Issa Abu-Dayyeh;Sarah Booth

  348
  Citations

• The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells.

  Simon Jones;Nicole Horwood;Andrew Cope;Francesco Dazzi

  324
  Citations

• Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

  Francesco Dazzi;Richard M. Szydlo;Nicholas C P Cross;C. Charles Craddock

  322
  Citations

• The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.

  Rajesh Ramasamy;Rajesh Ramasamy;Chih Kong Tong;Heng Fong Seow;Sharmili Vidyadaran

  291
  Citations

• HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation.

  Mauro Krampera;Mauro Krampera;Annalisa Pasini;Annalisa Pasini;Antonella Rigo;Antonella Rigo;Maria Teresa Scupoli;Maria Teresa Scupoli

  277
  Citations

• Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease.

  V. Tisato;K. Naresh;J. Girdlestone;C. Navarrete

  252
  Citations

• The immunosuppressive properties of mesenchymal stem cells.

  Georg Siegel;Richard Schäfer;Francesco Dazzi

  251
  Citations

• The immunomodulatory properties of mesenchymal stem cells

  Ilaria Marigo;Francesco Dazzi

  249
  Citations